CLINICAL_TRIALS
trial_result
· 2013-05-22
Clinical Trial Update: Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Summary
This entry notes the completion of a Phase 1 clinical trial evaluating MDX-1342 in patients with chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED